InvestorsHub Logo
icon url

rawsteel

01/08/20 10:25 AM

#2994 RE: Deagle #2993

Diffusion Pharmaceuticals, Inc. (NASDAQ:DFFN) stock decreased by 4.9% to $0.48. The most recent rating by H.C. Wainwright, on December 18, is at Buy, with a price target of $3.50.